Menu

Fennec Pharmaceuticals Inc. FENC

Full chart Compare
Set alert

Price alert · FENC

All alert types
9.81 USD +0.42 (+4.47%)

At closeNov 6, 2026, 4:01 PM EST

9.81 0.00 0.00%

After hours · Nov 6, 4:01 PM ET

9.20 Day range 10.05
5.77 52-week range 12.78
YTD
+27.40%
1 year
+22.63%

Revenue & Expenses

Revenue → Gross Profit: $40.88MGross Profit → Expenses: $40.88MRevenue → Cost of Revenue: $3.76MExpenses → Selling, General & Admin: $46.91MExpenses → Research & Development: $250.00KExpenses → Other Operating Expenses: $64.00KExpenses → Interest Expense: $2.08MExpenses → Other Expenses: $1.21MExpenses → Income Tax: $106.00KNet Loss → Expenses: $9.74MGross Profit$40.88MNet Loss$9.74MCost of Revenue$3.76MExpenses$50.62MSelling, General & Admin$46.91MResearch & Development$250.00KOther Operating Expenses$64.00KInterest Expense$2.08MOther Expenses$1.21MIncome Tax$106.00KRevenue$44.64M

Latest period ending Dec 31, 2025 · select a line to chart its full history

FENC annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
44.64M47.54M21.25M1.53M0
40.88M44.35M19.99M1.45M0
-6.28M2.57M-12.77M-22.59M-17.22M
-9.74M-436.00K-16.05M-23.71M-17.35M
-0.34-0.02-0.60-0.90-0.67
FENC annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
36.79M26.63M13.27M23.77M21.10M
70.55M44.95M26.86M26.94M22.41M
35.08M50.82M38.49M29.51M6.64M
35.47M-5.87M-11.62M-2.57M15.77M
FENC annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-12.47M26.98M-17.14M-18.06M-14.22M
22.63M-13.62M6.64M20.73M4.98M
10.15M13.37M-10.51M2.67M-9.24M